Comparison of Health Care Utilization and Costs for Patients with Asthma by Severity and Health Insurance in Thailand

Value in Health Regional Issues

Volumn 9, Issue , 2016, Pages 105-111

  Dilokthornsakul, Piyameth ^a   Lee, Todd A ^b   Dhippayom, Teerapon ^a   Jeanpeerapong, Napawan ^c   Chaiyakunapruk, Nathorn ^a,d,e,f  

^a NARESUAN UNIVERSITY   (Thailand)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c BUDDHACHINARAJ HOSPITAL   (Thailand)

^d MONASH UNIVERSITY MALAYSIA   (Malaysia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Asthma; Cost; Health care utilization; Severity

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; LEUKOTRIENE; XANTHINE OXIDASE INHIBITOR;

ADULT; ARTICLE; ASTHMA; CIVIL SERVANT MEDICAL BENEFIT SCHEME; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; INPATIENT CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; OUTPATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOCIAL SECURITY INSURANCE; THAILAND; UNIVERSAL COVERAGE SCHEME; AGED; ECONOMICS; HEALTH SERVICE; INSURANCE; MIDDLE AGED; UTILIZATION; YOUNG ADULT;

ADULT; AGED; ASTHMA; FEMALE; HEALTH SERVICES; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THAILAND; UNIVERSAL COVERAGE; YOUNG ADULT;

EID: 84964526771     PISSN: 22121099     EISSN: 22121102     Source Type: Journal    
DOI: 10.1016/j.vhri.2016.03.001     Document Type: Article

References (38)

1. Bahodori K., Doyle-Waters M.M., Marra C., et al. Economic burden of asthma: a systematic review. BMC Pulm Med 2009, 9:1-16.
2. National Heart Lung and Blood Institute. National Asthma Education and Prevention Program: Expert Panel Report 3: guidelines for the diagnosis and management of asthma. 2007. Available from: . [Accessed January 9, 2013]. http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.pdf.
3. Masoli M., Fabian D., Holt S., Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy 2004, 59:469-478.
4. Akinbami L.J., Moorman J.E., Liu X. Asthma Prevalence, Healthcare Use and Mortality: United States, 2005-2009. National Health Statistics Reports. Atlanta, GA, USA: National Center for Health Statistics, Centers for Disease Control and Prevention 2011, 1-16.
5. The International Union Against Tuberculosis and Lung Disease. The global asthma report 2011. Available from: . [Accessed January 8, 2013]. http://www.globalasthmareport.org.
6. Boonsawat W., Charoenphan P., Kiatboonsri S., et al. Survey of asthma control in Thailand. Respirology 2004, 9:373-378.
7. Chuesakoolvanich K. Cost of hospitalizating asthma patients in a regional hospital in Thailand. Respirology 2007, 12:433-438.
8. Global Initiative for Asthma. Global strategy for asthma management and prevention revised updated 2015. Available from: . [Accessed November 5, 2015]. http://www.ginasthma.org/.
9. Cisternas M.G., Blance P.D., Yen I.H., et al. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol 2003, 111:1212-1218.
10. Sadatsafavi M., Lynd L., Marra C., et al. Direct health care costs associated with asthma in British Columbia. Can Respir J 2010, 17:74-80.
11. Kim S.H., Kim T.W., Kwon J.W., et al. Economic costs for adult asthmatics according to severity and control status in Korean tertiary hospitals. J Asthma 2012, 49:303-309.
12. Coker T.R., Kaplan R.M., Chung P.J. The association of health insurance and disease impairment with reported asthma prevalence in U.S. children. Health Serv Res 2012, 47:431-445.
13. Vila D., Rand C.S., Cabana M.D., et al. Disparities in asthma medication dispensing patterns: the case of pediatric asthma in Puerto Rico. J Asthma 2010, 47:1136-1141.
14. Schumock G.T., Walton S.M., Lee T.A., et al. Comparative effectiveness of paricalcitol versus cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. Nephron Clin Pract 2011, 117:c151-c159.
15. Jordan N., Sohn M.W., Bartle B., et al. Association between chronic illness complexity and receipt of evidence-based depression care. Med Care 2014, 52:S126-S131.
16. Lee T.A., Chang C.L., Stephenson J.J., et al. Impact of asthma controller medications on medical and economic resource utilization in adult asthma patients. Curr Med Res Opin 2010, 26:2851-2860.
17. Schatz M., Zeiger R.S., Vollmer W.M., et al. Development and validation of a medication intensity scale derived from computerized pharmacy data that predicts emergency hospital utilization for persistent asthma. Am J Manage Care 2006, 12:478-484.
18. Kawasumi Y., Abrahamowicz M., Ernst P., Tamblyn R. Development and validation of a predictive algorithm to identify adult asthmatics from medical services and pharmacy claims databases. Health Serv Res 2011, 46:939-963.
19. Paris J., Peterson E.L., Wells K., et al. Relationship between recent short-acting β-agonist use and subsequent asthma exacerbations. Ann Allergy Asthma Immunol 2008, 101:482-487.
20. Holt E.W., Cook E.F., Covar R.A., et al. Identifying the components of asthma health status in children with mild to moderate asthma. J Allergy Clin Immunol 2008, 121:1175-1180.
21. Pongpattrachai D., Sakulpanich T., Thammawantha P., Wongsilpa U. Comparison of Cost of Care Using Diagnosis Related Group Between Teaching and Non-Teaching Hospital in Thailand: Cost of Care in Teaching Hospital in Thailand 2012, Health Insurance System Research Office, Bangkok, Thailand.
22. Bank of Thailand. Daily foreign exchange rate. Available from: . [Accessed January 8, 2013]. http://www.bot.or.th/English/Statistics/FinancialMarkets/ExchangeRate/_layouts/Application/ExchangeRate/ExchangeRate.aspx.
23. Dodd S., Bassi A., Bodger K., Williamson P. A comparison of multivariable regression models to analyse cost data. J Eval Clin Pract 2006, 12:76-86.
24. ten Brinke A., Sterk P.J., Masclee A.A., et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 2005, 26:812-818.
25. Dilokthornsakul P., Chaiyakunapruk N., Schumock G.T., Lee T.A. Calendar time-specific propensity score analysis for observational data: a case study estimating the effectiveness of inhaled long-acting beta-agonist on asthma exacerbations. Pharmacoepidemiol Drug Saf 2014, 23:152-164.
26. Global Initiative for Asthma. Global strategy for asthma management and prevention: 2014. Available from: . [Accessed July 7, 2014]. http://www.ginasthma.org.
27. Parsons J.P., Mastronarde J.G. Gastroesophageal reflux disease and asthma. Curr Opin Pulm Med 2010, 16:60-63.
28. Black M.H., Zhou H., Takayanagi M., et al. Increased asthma risk and asthma-related health care complications associated with childhood obesity. Am J Epidemiol 2013, 178:1120-1128.
29. Ross K.R., Hart M.A. Assessing the relationship between obesity and asthma in adolescent patients: a review. Adolesc Health Med Ther 2013, 4:39-49.
30. Cook R.D. Detection of influential observation in linear regression. Technometrics 1977, 19:15-18.
31. Schwenkglenks M., Lowy A., Anderhub H., Szucs T.D. Costs of asthma in a cohort of Swiss adults: associations with exacerbation status and severity. Value Health 2003, 6:75-83.
32. Serra-Batlles J., Plaza V., Morejon E., et al. Costs of asthma according to the degree of severity. Eur Respir J 1998, 12:1322-1326.
33. Gypmantasiri S. Costs of illness of asthma in Chiang Mai and Lumphun. Chiang Mai Univ J Econ 2007, 11:1-9.
34. Thavorn K., Chaiyakunapruk N. A cost-effetiveness analysis of a community pharmacist-based smoking cessation programme in Thailand. Tobacco Control 2008, 17:177-182.
35. Thammatach-aree J. Health systems, public health programs, and social determinants of health: Thailand. Available from: . 2011. [Accessed February 9, 2013]. http://www.who.int/social_determinants.
36. Blanchette C.M., Culler S.D., Ershoff D., Gutierrez B. Association between previous health care use and initiation of inhaled corticosteroid and long-acting β2-adrenergic agonist combination therapy among US patients with asthma. Clin Ther 2009, 31:2574-2583.
37. Schatz M., Zeiger R.S. Improving asthma outcomes in large populations. J Allergy Clin Immunol 2011, 128:273-277.
38. Wojtczak H.A., Wachter A.M., Lee M., et al. Understanding the relationship among pharmacoadherence measures, asthma control test scores, and office-based spirometry. Ann Allergy Asthma Immunol 2012, 109:3-107.